UK manufacturers produced 14000 ventilator and exported to the surplus ventilators.
In mid of March, there were a lot of chance of increased number of COVID-19 cases. At that time Boris Johnson, British Prime Minister, ordered health product industry to make 30,000 ventilators. There was risk that the NHS supplies could be overwhelmed.
He thanked the efforts made by the manufacturers. Moreover, he said that everyone who needed, had access to ventilator. NHS has the necessary machines which are need for saving lives against this deadly virus.
An official figure reported that in April, medical ventilator beds reached its peak, 3301. Thus, this indicated that demand was less than half of the UK’s capacity, nearly 9,000.
The prime minister asked for 30,000 ventilators for the treatment of COVID-19 patients. He ordered after the scientific modelling from China which indicated a huge number of ventilators maybe needed.
The UK’s health secretary, Matt Hancock, decreased the target to 18,000. Although people are practicing social distancing and other safety measures, ventilator capacity of NHS has not been increased.
On Friday, the Cabinet office said that the company has stopped the production of the ventilators and the present model; which is made by Penlon. Now, the medical device company can export them.
Moreover, authorities have approved four different devices for production during the challenge. This boosted the UK’s supply up to 25,000.
According to Cabinet office, the independent testing has approved CoVent, made by Dyson and three other design can also be used.
Dr Tom Clutton, the director of the medical devices testing evaluation center, tested the devices. He said that the making of ventilator is a long process. The processes include designing, manufacturing and testing. If the designs does not work, other design has to be manufactured. In short, the process takes almost a year.
He appreciated the progress made by the health product companies. Furthermore, he said that the companies did great and fulfilled the ventilators’ needs in months.
Upon successful testing of different devices, Clutton remarked that the results impressed him that several new models met the regulator’s requirements.
“These models would all have been clinically usable as pandemic ventilators and could have supported large numbers of critically ill patients,” he said.